News center and blog

Your source for the latest content and news from Cytiva.

pictogram-centrifugation
60% Complete

APPLIED FILTERS:

Cytiva and Testa Center are inviting scientific companies and researchers to compete in the 2024 Testa Challenge. Winners have the opportunity to accelerate their innovations around the scale up and manufacturing of antibody (Ab) intermediates, as it relates to Ab-drug conjugates (ADCs).

Read More
Press Release
Cytiva again receives platinum EcoVadis ranking for sustainability
Wednesday, November 8, 2023

Cytiva is among the top one percent of companies to receive the prestigious platinum ranking from EcoVadis, a leading provider of business sustainability performance rankings.

Read More
Press Release
Cytiva expands scientific, digital, and training offering in China
Tuesday, September 12, 2023

Recognizing the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva has opened its expanded Shanghai facility.

Read More

Cytiva and LevitasBio join forces to transform single-cell workflow.

Read More

Cytiva and RoosterBio collaborate to improve the exosome purification process currently slowing adoption of promising gene therapies and other new modalities.

Read More

Collaboration will boost capabilities to deliver cancer treatment within Thailand and to Southeast Asia by 2025

Read More

Cytiva introduces the innovative Cytiva Protein Select technology, designed to streamline and accelerate recombinant protein purification. The self-cleaving traceless tag and complementary affinity chromatography resin standardizes purification for any protein, rendering it unnecessary to use specific affinity binding partners for each protein.

Read More

The manufacturing facility in Pune will double Cytiva’s manufacturing capacity in India and the Experience Center will provide critical training programs to accelerate the development of novel therapeutics.

Read More

Cytiva launches the NanoAssemblr commercial formulation system for lipid nanoparticle medicines. It offers end-to-end manufacturing from clinical development to commercial production, using scalable mixing technology.

Read More